So who is coming to MedCity CONVERGE, MedCityNews.com’s one-day summit on innovation and convergence July 10 in Philadelphia? Consider these key statistics:
- 25 percent have the title CEO, founder or president;
- 15 percent have a vice president’s title;
- 5 percent have “innovation” somewhere in their title;
- 1 is an “executive rebel.”
And that’s just the beginning of an innovative collection of entrepreneurs, investors, hospital and insurance executives, medical device and pharmaceutical leaders, and digital health pioneers who — no matter what their titles are — are dedicated to setting the agenda for healthcare and the life sciences for years to come. Buy your tickets now for MedCity CONVERGE and take part in one of the few events that gather the entire healthcare ecosystem in one place to discuss key strategies around mobile health and online collaboration, technology transfer and investment trends, the future of innovation in the medical device sector, and much more.
Do you want to know some of the companies planning to attend? Below is a selection of the organizations sending attendees to CONVERGE. I guarantee you won’t know all the names of these amazing companies, which is all the more reason to come and network with the upstarts and the dominant names in medical innovation.
- 1docway
- 3M
- AcryMed
- AssureRX
- Bioconnect Systems
- Blueprint Health
- University of North Carolina
- CertiRX
- Children’s Hospital, Boston
- Children’s Mercy Hospital
- Chrysalis Ventures
- Claremont Creek Ventures
- CoverMyMeds
- Deloitte Center for Health Solutions
- DocPhin
- DreamIt Ventures
- Drexel University
- ECRI Institute
- Edison Ventures
- Endo
- Endomedix
- Force Therapeutics
- GestSure
- GSK
- iCouch
- Independence Blue Cross
- InSight Telepsychiatry, LLC.
- Janssen Healthcare Innovation at Johnson & Johnson
- Lockheed Martin
- Medivo
- Medtronic
- myClin
- Myeloma Ventures
- MyMedChoice
- Penn Medicine
- Pennsylvania Angel Network
- Pfizer
- Pilljogger
- Podimetrics
- PricewaterhouseCoopers
- Robert Wood Johnson Foundation
- Safeguard Scientifics
- Sanofi
- SAP
- Shire
- Startup Health
- The Children’s Hospital of Pennsylvania
- Thomas Jefferson University
- UnitedHealth Group
- University of Iowa
- Zeel Networks
- Zemoga
Do you want to know everyone who’s coming? The only way to do that is to come to CONVERGE on July 10 in Philadelphia. The old ways of thinking about medical innovation are over. There are no silos. There is just one mass of innovators ready to set the agenda for the new products and insights yet to come. Come to CONVERGE and take part in that discussion.
[Photo courtesy of the Millennier]
A Deep-dive Into Specialty Pharma
A specialty drug is a class of prescription medications used to treat complex, chronic or rare medical conditions. Although this classification was originally intended to define the treatment of rare, also termed “orphan” diseases, affecting fewer than 200,000 people in the US, more recently, specialty drugs have emerged as the cornerstone of treatment for chronic and complex diseases such as cancer, autoimmune conditions, diabetes, hepatitis C, and HIV/AIDS.
